-
Three-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection – Early Impact of Interleukin-6 Blockade on Donor-Specific Antibody Levels, Rejection Morphology and Gene Expression
-
Three-Year Post-Transplant Outcome of Desensitized Mechanical Circulatory Support Patients Awaiting Heart Transplantation
-
Thymic B Cells: A Means to Control Regulatory Tolerance
-
Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All
-
Thymoglobulin Dose and Incidence of Biopsy Proven Acute Rejections in the Early Post Transplant Period
-
Thymoglobulin for Induction Less is Clearly More!
-
Thymoglobulin Induction in Kidney Transplant Recipients: A Single Center Experience Comparing 3 Mg/kg vs 5 Mg/kg Cumulative Dosing
-
TIM-4+ Kupffer Cells Play Homeostatic Roles in Liver Ischemia Reperfusion Injury
-
Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E
-
Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea
- « Previous Page
- 1
- …
- 203
- 204
- 205
- 206
- 207
- …
- 223
- Next Page »